Showing results (261-270 of 275) with videos related to
Sort By:
Pageof 28
Analytical and Bioanalytical Chemistry|January 29, 2022
Automated liquid handling robot for rapid lateral flow assay developmentCaitlin E Anderson, Toan Huynh, David J Gasperino, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 4, 2023
Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT studyStacey L Martiniano, Silvia M Caceres, Katie Poch, et al.American Journal of Respiratory and Critical Care Medicine|May 8, 2010
Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosisJerry A Nick, Cathy S Chacon, Sara J Brayshaw, et al.Journal of Bacteriology|September 9, 2020
Nanoluciferase Reporter Mycobacteriophage for Sensitive and Rapid Detection of Mycobacterium tuberculosis Drug SusceptibilityParas Jain, Spencer Garing, Deepshikha Verma, et al.ACS Omega|October 5, 2021
Antibody Screening Results for Anti-Nucleocapsid Antibodies Toward the Development of a Lateral Flow Assay to Detect SARS-CoV-2 Nucleocapsid ProteinDavid M Cate, Joshua D Bishop, Helen V Hsieh, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 23, 2021
PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapyDave P Nichols, Scott H Donaldson, Carla A Frederick, et al.BMJ Open|August 11, 2019
Testing a support programme for opioid reduction for people with chronic non-malignant pain: the I-WOTCH randomised controlled trial protocolHarbinder K Sandhu, Charles Abraham, Sharisse Alleyne, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 24, 2022
Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GISarah Jane Schwarzenberg, Phuong T Vu, Michelle Skalland, et al.Plos One|May 17, 2021
Characterization of oral swab samples for diagnosis of pulmonary tuberculosisRachel C Wood, Alfred Andama, Gleda Hermansky, et al.The Lancet. Respiratory Medicine|November 7, 2022
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trialsNicole Mayer-Hamblett, Felix Ratjen, Renee Russell, et al.Pageof 28